rbd003

Robert B. Den, MD

Contact Dr. Den

111 South 11th Street
Room G-301, Bodine Center
Philadelphia, PA 19107

(215) 955-6702
(215) 955-0412 fax

Most Recent Peer-reviewed Publications

  1. Low rates of androgen deprivation therapy use with salvage radiation therapy in patients with prostate cancer after radical prostatectomy
  2. The role of genomic techniques in predicting response to radiation therapy
  3. Increasing faculty participation in resident education and providing cost-effective self-assessment module credit to faculty through resident-generated didactics
  4. Genomic classifier augments the role of pathological features in identifying optimal candidates for adjuvant radiation therapy in patients with prostate cancer: Development and internal validation of a multivariable prognostic model
  5. Individual patient-level meta-Analysis of the performance of the decipher genomic classifier in high-risk men after prostatectomy to predict development of metastatic disease
  6. Transcriptome evaluation of the relation between body mass index and prostate cancer outcomes
  7. Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality
  8. Cost-effectiveness of the Decipher Genomic Classifier to Guide Individualized Decisions for Early Radiation Therapy After Prostatectomy for Prostate Cancer
  9. siRNA-Encapsulated Hybrid Nanoparticles Target Mutant K-ras and Inhibit Metastatic Tumor Burden in a Mouse Model of Lung Cancer
  10. MicroRNA-194 promotes prostate cancer metastasis by inhibiting SOCS2
  11. RB loss promotes prostate cancer metastasis
  12. Low PCA3 expression is a marker of poor differentiation in localized prostate tumors: Exploratory analysis from 12,076 patients
  13. Prognostic outlier genes for enhanced prostate cancer treatment
  14. Multi-institutional Analysis Shows that Low PCAT-14 Expression Associates with Poor Outcomes in Prostate Cancer
  15. Hematologic Toxicity of Concurrent Administration of Radium-223 and Next-generation Antiandrogen Therapies
  16. Molecular Analysis of Low Grade Prostate Cancer Using a Genomic Classifier of Metastatic Potential
  17. Multi-institutional Evaluation of Elective Nodal Irradiation and/or Androgen Deprivation Therapy with Postprostatectomy Salvage Radiotherapy for Prostate Cancer
  18. Stromal Gene Expression is Predictive for Metastatic Primary Prostate Cancer
  19. Salvage Radiation Therapy Dose Response for Biochemical Failure of Prostate Cancer After Prostatectomy—A Multi-Institutional Observational Study
  20. Decipher correlation patterns post prostatectomy: Initial experience from 2 342 prospective patients